Nirvana Life Sciences Inc's total assets for Q1 2025 were C$18.44K, a decrease of -5.18% from the previous quarter. TSE:NIRV total liabilities were C$546.17K for the fiscal quarter, a -63.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.